ORKA - Latest News
Oruka Therapeutics, Inc. (ORKA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $6.00B. Beta to the broader market is -0.39.
The article list below shows the most recent ORKA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ORKA Headlines
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
zacks.com - Aug 28, 2026
Oruka's three-month rally reflects investor confidence in ORKA-001, with key clinical data and pipeline milestones scheduled ahead.
BlackRock Inc. Purchases Shares of 4,990,181 Oruka Therapeutics, Inc. $ORKA
defenseworld.net - Aug 25, 2026
BlackRock Inc. purchased a new position in Oruka Therapeutics, Inc.
Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
globenewswire.com - Aug 24, 2026
MENLO PARK, Calif. , Aug.
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
zacks.com - Aug 11, 2026
PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com - Aug 10, 2026
EVERLAST-A Week 28 data expected at the end of 3Q 2026; 52-week data for all participants expected in December 2026 EVERLAST-B fully enrolled ahead of
How News Affects ORKA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ORKA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ORKA news questions
- What is the latest ORKA news headline?
- The most recent ORKA headline (Aug 28, 2026) is "ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ORKA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ORKA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ORKA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.